T1	Outcomes 158 180	toxicity and tolerance
T2	Outcomes 978 988	dose level
T3	Outcomes 1004 1013	tolerable
T4	Outcomes 1053 1072	grade 3/4 toxicity.
T5	Outcomes 1152 1161	toxicity.
T6	Outcomes 1179 1188	tolerated
T7	Outcomes 1261 1302	mild-to-moderate constitutional symptoms.
T8	Outcomes 1303 1321	Grade 3/4 toxicity
T9	Outcomes 1352 1381	Interleukin-2 dose reductions
T10	Outcomes 1460 1469	toxicity.
T11	Outcomes 1529 1536	relapse
T12	Outcomes 1556 1560	died
T13	Outcomes 1568 1583	Median survival
T14	Outcomes 1607 1640	3-year disease-free survival rate
T15	Outcomes 1650 1673	Median overall survival
T16	Outcomes 1709 1729	3-year survival rate
T17	Outcomes 1839 1879	disease-free survival or 3-year survival
T18	Outcomes 2110 2119	tolerated
T19	Outcomes 2287 2327	clinical efficacy and favorable toxicity
